Pulmonale neuroendokrine Tumoren in der neuen WHO-Klassifikation 2015 (original) (raw)

Literatur

  1. Ampollini L, Carbognani P, Rusca M, Bobbio A (2010) Resection of giant typical carcinoid tumor with cardiopulmonary bypass support. Thorac Cardiov Surg 58:494–502
    Article Google Scholar
  2. Beasley MB, Brambilla E, Chirieac LR, Austin JHM, Devesa SS, Hasleton P, Jett J, Marchevsky AM, Nicholson S, Papotti M, Pelosi G, Rami-Porta R, Scagliotti G, Thunnissen E, Travis WD, van Schil P, Yang P (2015) Carcinoid tumor. In: Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG (Hrsg) WHO Classification of tumors of the lung, pleura, thymus and heart. IARC Press, Lyon, S 73–77
    Google Scholar
  3. Bohle RM, Kim YJ, Schnabel PA (2015) Lungentumoren – Lehrserie Nr. 221, Internationale Akademie für Pathologie, Deutsche Abteilung e. V.
  4. Brambilla E, Beasley MB, Austin JHM, Capelozzi VL, Chirieac LR, Devesa SS, Frank GA, Gazdar A, Ishikawa Y, Jen J, Jett J, Marchevsky AM, Nicholson S, Pelosi G, Powell CA, Rami-Porta R, Scagliotti G, Thunissen E, Travis WD, van Schil P, Yang P (2015) Small cell carcinoma. In: Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG (Hrsg) WHO classification of tumors of the lung, pleura, thymus and heart. IARC Press, Lyon, S 63–68
    Google Scholar
  5. Brambilla E, Beasley MB, Chirieac LR, Austin JHM, Capelozzi VL Devesa SS, Gazdar A, Ishikawa Y, Jett J, Nicholson S, Pelosi G, Powell CA, Rami-Porta R, Riely G, Scagliotti G, Travis WD, van Schil P, Yang P, Yankelevitz D (2015) Large cell neuroendocrine carcinoma. In: Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG (Hrsg) WHO classification of tumors of the lung, pleura, thymus and heart. IARC Press, Lyon, S 69–72
    Google Scholar
  6. Brokx HAP, Paul MA, Postmus PE, Sutedja TG (2015) Long-term follow-up after first-line bronchoscopic therapy in patients with bronchial carcinoids. Thorax. (Epüb ahead of print)
  7. Collisson EA, Campbell JD, Brooks AN et al (2014) Comprehensive molecular profiling of lung adenocarcinoma. Cancer Genome Atlas Research Network. Nature 511:543–540
  8. Diakatou E, Alexandri KI, Tsolakis AV, Kontogeorgos G, Chatzellis E, Leonti A, Kaltsas GA (2015) Somatostatin and dopamine receptor expression in neuroendocrine neoplasms; correlation of immunohistochemical findings with somatostatin receptor scintigraphy visual scores. Clin Endocrinol (Oxf.). doi:10.1111/cen.12775. vv
  9. Dong HY, Liu W, Cohen P, Mahle CE, Zhang W (2005) B-cell specific activation protein encoded by the PAX-5 gene is commonly expressed in Merkel cell carcinoma and small cell carcinomas. Am J Surg Pathol 29:687–692
    Article PubMed Google Scholar
  10. Fernandez-Cuesta L, Peifer M, Lu X, Sun R, Ozrtic L, Seidel D, Zander T, Leenders F, George J, Müller C, Dahmen I, Pinther B, Bosco G, Konrad K, Altmüller J, Nürnberg P, Achter V, Lang U, Schneider PM, Bogus M, Soltermann A, Brustugun OT, Helland A, Solberg S, Lund-Iversen M, Ansén S, Stoelben E, Wright GM, Russell P, Wainer Z, Solomon B, Field JK, Hyde R, Davies MPA, Heukamp LC, Petersen I, Perner S, Lovly CM, Cappuzzo F, Travis WD, Wolf J, Vingron M, Brambilla E, Haas SA, Buettner R, Thomas RK (2014) Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids. Nat Commun 5:3518. doi:10.1038/ncomms4518
    Article Google Scholar
  11. Gazdar AF, Savage TK, Johnson JE, Berns A, Sage J, Linoilla RI, MacPherson D, McFadden DG, Farago A, Jacks T, Travis WD, Brambilla E (2015) The comparative pathology of genetically engineered mouse models for neuroendocrine carcinomas of the lung. J Thorac Oncol 10:553–564
    Article CAS PubMed Google Scholar
  12. Gosney JR, Austin JHM, Jett J, Nicholson AG, Nicholson S, Rami-Porta R, Travis WD, van Schil P (2015) Preinvasive leason – Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia. In: Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG (Hrsg) WHO Classification of tumors of the lung, pleura, thymus and heart. IARC Press, Lyon, S 78–79
    Google Scholar
  13. Gottschling S, Jensen K, Herth FJF, Thomas M, Schnabel PA, Herpel E (2013) Lack of prognostic significance of neuroendocrine differentiation and stem cell antigen co-expression in resected early-stage non-small cell lung cancer. Anticancer Res 33:981–990
    PubMed Google Scholar
  14. Grohé C (2014) Neuroendokrine Lungentumoren. Pneumologie 68:455–477
    Article PubMed Google Scholar
  15. Hassan MM, Phan A, Li D, Dagohoy CG, Leary C, Yao JC (2008) Risk factors associated with neuroendocrine tumors: A U.S.-based case-control study. Int J Cancer 123:867–873
    Article CAS PubMed Google Scholar
  16. Helmbold P, Lahtz C, Herpel E, Schnabel PA, Dammann RH (2009) Frequent hypermethylation of RASSF1A tumour suppressor gene promoter and presence of Merkel cell polyomavirus in small cell lung cancer. Eur J Cancer 45:2207–2211
    Article CAS PubMed Google Scholar
  17. Huwer H, Kalweit G, Schäfer H, Eltze E (2011) Pulmonales Paragangliom: Fallbericht und Literaturübersicht. Pneumologie 65:742–744
    Article CAS PubMed Google Scholar
  18. Iyoda A, Jiang S-X, Travis WD, Kurouzu N, Ogawa F, Amano H, Sato Y, Rusch VW, Saegusa M, Satoh Y (2013) Clinicopathological features and the impact of the new TNM classification of malignant tumors in patients with pulmonary large cell neuroendocrine carcinoma. Mol Clin Oncol 1:437–443
    PubMed Central CAS PubMed Google Scholar
  19. Johney EC, Pfannschmidt J, Rieker RJ, Schnabel PA, Mechtersheimer G, Dienemann H (2006) Diffuse idiopathic pulmonary neuroendocrine cell hyperplasio and a typical carcinoid tumor. J Tharac Cardiovasc Surg 131:1207–1208
    Article Google Scholar
  20. Junker K, Länger F, Schnabel PA (2013) Update Pneumopathologie – Bericht der AG Pneumopathologie der Deutschen Gesellschaft für Pathologie. Pathologe 34(Suppl 2):304–307
    Article PubMed Google Scholar
  21. Kaemmerer D, Specht E, Sänger J, Wirtz RM, Sayeg M, Schulz S, Lupp A (2015) Somatostatin receptors in bronchopulmonary neuroendocrine neoplasms: new diagnostic, prognostic, and therapeutic markers. J Clin Endocrinol Metab 100:831–840
    Article CAS PubMed Google Scholar
  22. Kanteti R, Nallasura V, Loganathan S, Tretiakova M, Kroll T, Krishnaswamy S, Faoro L, Cagle P, Husain AN, Vokes EE, Lang D, Salgia R (2009) PAX5 is expressed in small cell lung cancer and positively regulates c-Met transcription. Lab Invest 89:301–314
    Article PubMed Central CAS PubMed Google Scholar
  23. Le Treut J, Sault MC, Lena H, Souquet PJ, Vergnenegre A, Le Caer H, Berard H, Boffa S, Monnet I, Damotte D, Chouaid C (2013) Multicentre phase II study of cisplatin-etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study. Ann Oncol 24:1548–1552
    Article PubMed Google Scholar
  24. Mireskandari M, Abdirad A, Zhang Q, Dietel M, Petersen I (2013) Association of small foci of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) with adenocarcinoma of the lung. Path Res Pract 209:578–584
    Article CAS PubMed Google Scholar
  25. Nenekidis I, Stathopoulos GT, Anagnostakou V, Kokkori A, Dedeilias P, Kokotsakis J, Argiriou M, Zisis C (2011) Atypical pulmonary carcinoid tumour in a 28-year-old nonsmoker with Prader-Willi syndrome. Eur Respir J 38:1230–1233
    Article CAS PubMed Google Scholar
  26. Peifer M, Fernández-Cuesta L, Sos ML et al (2012) Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet 44:1104–1110
  27. Pelosi G, Rodriguez J, Viale G, Rosai J (2005) Typical and atypical pulmonary carcinoid tumor overdiagnosed as small-cell carcinoma on biopsy specimens: a major pitfall in the management of lung cancer patients. Am J Surg Pathol 29:179–187
    Article PubMed Google Scholar
  28. Petersen I, Schnabel PA (2011) Neues zur Lungenpathologie. Bericht der Arbeitsgemeinschaft Pneumopathologie der Deutschen Gesellschaft für Pathologie. Pathologe 32 (Suppl 2):351–357
    Article PubMed Google Scholar
  29. Righi L, Volante M, Tavaglione V, Billè A, Daniele L, Angusti T, Inzani F, Pelosi G, Rindi G, Papotti M (2010) Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 ‚clinically aggressive‘ cases. Ann Oncol 21:548–555
    Article CAS PubMed Google Scholar
  30. Rindi R, Klersy C, Inzani F, Fellegara G, Ampolloni L, Ardizzoni A, Campanini N, Carbognani P, De Pas DM, Galetta D, Granone PL, Righi L, Rusca M, Spaggiari L, Tiseo M, Viale G, Volante M, Papotti M, Pelosi G (2014) Grading the neuroendocrine tumors of the lung: an evidence-based proposal. Endocr Relat Cancer. doi:10.1530/ERC-13-0246
  31. Rossi G, Mengoli MC, Cavazza A, Nicoli D, Barbareschi M, Cantaloni C, Papotti M, Tironi A, Graziano P, Paci M, Stefani A, Migaldi M, Sartori G, Pelosi G (2014) Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology. Virchows Arch 464:61–68
    Article CAS PubMed Google Scholar
  32. Sachithanandan N, Harle RA, Burgess JR (2005) Bronchopulmonary carcinoid in multiple endocrine neoplasia type 1. Cancer 103:509–515
    Article PubMed Google Scholar
  33. Schnabel PA, Junker K (2014) Neuroendokrine Tumoren der Lunge – Vom kleinzelligen Lungenkarzinom bis zur diffusen idiopathischen pulmonalen neuroendokrinen Zellhyperplasie. Pathologe 35:557–564
    Article CAS PubMed Google Scholar
  34. Schnabel PA, Petersen I, Junker K (2012) Neueste Aktivitäten in der Pneumopathologie -Bericht der Arbeitgemeinschaft Pneumopathologie der Deutschen Gesellschaft für Pathologie. Pathologe 33(Suppl 2):351–354
    Article PubMed Google Scholar
  35. Schnabel PA, Veith C, Zaharia C, Langer F, Seidel RM, Wehler TC, Bohle RM (2015) Co-occurrence of DIPNECH and of meningotheliosis with a pulmonary adenocarcinoma (pADC) in one lung lobe – Consequences for sampling. (Zur Publikation eingereicht)
  36. Seidel D, Zander T, Heukamp LC et al (2013) A genomics-based classification of human lung tumors – Clinical Lung Cancer Genome Project (CLCGP); Network Genomic Medicine (NGM). Sci Transl Med 5(209):209ra153
  37. Sica G, Vazquez MF, Altorki N, Port J, Lee PC, Liu Y, Hyjek E, Saqi A (2008) PAX-5 expression in pulmonary neuroendocrine neoplasms. Am J Clin Pathol 129:556–562
    Article PubMed Google Scholar
  38. Song J, Li M, Tretiakova M, Salgia R, Cagle PT, Husain AN (2010) Expression patterns of PAX5, c-MET and Paxillin in neuroendocrine tumors of the lung. Arch Pathol Lab Med 134:1702–1705
    PubMed Central PubMed Google Scholar
  39. Sterlacci W, Fiegl M, Hilbe W, Auberger J, Mikuz G, Tzankov A (2009) Clinical relevance of neuroendocrine differentiation in non-small cell lung cancer assessed by immunohistochemistry: a retrospective study on 405 surgically resected cases. Virchows Arch 455:125–132
    Article CAS PubMed Google Scholar
  40. Travis WD, Brambilla E, Müller-Hermelink HK et al (2004) Tumors of the Lung, Pleura Thymus and Heart, World Health Organization classification of tumors. Pathology and genetics. IARC Press, Lyon
    Google Scholar
  41. Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG (2015) WHO Classification of tumors of the lung, pleura, thymus and heart. IARC Press, Lyon
    Google Scholar
  42. Travis WD, Brambilla E, Noguchi M et al (2011) International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6:244–285
    Article PubMed Google Scholar
  43. Thunissen E, Kerr KM, Herth FJF, Lantuejoul S, Papotti M, Rintoul RC, Rossi G, Skov BG, Weynand B, Bubendorf L, Katrien G, Johansson L, López-Rios F, Ninane V, Olzewski W, Popper H, Jaume S, Schnabel PA, Thiberville L, Laenger F (2012) The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group. Lung Cancer 76:1–18
    Article Google Scholar
  44. Volante M, Gatti G, Papotti M (2015) Classification of lung neuroendocrine tumors: lights and shadows. Endocrine. (Epub ahead of print)
  45. Walter RF, Mairinger FD, Werner R, Ting S, Vollbrecht C, Theegarten D, Christoph DC, Zarogoulidis K, Werner KW, Zarogoulidis P, Wohlschläger J (2015) SOX4, SOX11 and PAX6 mRNA expression was identified as a (prognostic) marker for the aggressiveness of neuroendocrine tumors of the lung by using next-generation expression analysis (NanoString). Future Oncol 7:1027–1036
    Article Google Scholar
  46. Warth A, Endris V, Penzel R, Weichert W (2014) Molecular pathology of lung cancer. State of the art 2014. Pathologe 35:565–573
    Article CAS PubMed Google Scholar
  47. Warth A, Fink L, Fisseler-Eckhoff A, Jonigk, Keller M, Ott G, Rieker RJ, Sinn P, Söder S, Soltermann A, Willenbrock K, Weichert W, on behalf of the Pulmonary Pathology Working Group of the German Society of Pathology (2013) Interobserver agreement if proliferation index (Ki-67) outperforms mitotic count in pulmonary carcinoids. Virchows Arch 462:507–513
  48. Warth A, Herpel E, Krysa S, Hoffmann H, Schnabel PA, Schirmacher P, Mechtersheimer G, Bläker H (2009) Chromosomal instability is more frequent in metastasized than in non-metastasized pulmonary carcinoids but is not a reliable predictor of metastatic potential. Exp Mol Med 41:349–353
    Article PubMed Central CAS PubMed Google Scholar
  49. Warth A, Herpel E, Schmähl A, Storz K, Schnabel PA (2008) Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) in association with an adenocarcinoma: a case report. J Medical Case Reprts 2:21–23
    Article Google Scholar
  50. Warth A, Krysa S, Zahel T, Hoffmann H, Schirmacher P, Schnabel PA, Herpel E (2010) S100 protein positive sustentacular cells in pulmonary carcinoids and thoracic paragangliomas: differential diagnostic and prognostic evaluation. Pathologe 31:379–384
    Article CAS PubMed Google Scholar
  51. Zahel T, Krysa S, Herpel E, Stenzinger A, Goeppert B, Schirmacher P, Schnabel PA, Warth A (2012) Phenoptyping of pulmonary carcinoids and a Ki-67-based grading approach. Virchows Arch 460:299–308
    Article CAS PubMed Google Scholar

Download references